A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in the management of Raynaud’s phenomenon. - Asasantin retard therapy in the management of Raynaud's phenomenon A short-term open-label single site pilot study evaluating the use of asasantin retardtherapy in the ...
A short-term open-label single site pilot study evaluating the use of asasantin retard therapy in the management of Raynaud’s phenomenon. - Asasantin retard therapy in the management of Raynaud's phenomenon A short-term open-label single site pilot study evaluating the use of asasantin retardtherapy in the ...